5 Numbers That Should Get MannKind Investors Excited
MannKind (NASDAQ: MNKD) hasn't exactly given investors a whole lot to get excited about in recent years. That could be changing, though. Since May, MannKind stock has soared more than 130% and now stands as one of the hottest biotech stocks on the market.
Michael Castagna, MannKind's CEO, spoke on Monday morning at the Cantor Fitzgerald Global Healthcare Conference. He mentioned five numbers in his presentation that should get MannKind investors even more excited.
Image source: Getty Images.
Source: Fool.com
Sanofi S.A. ADR Stock
€51.00
-0.980%
Sanofi S.A. ADR is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
With a target price of 55 € there is a slightly positive potential of 7.84% for Sanofi S.A. ADR compared to the current price of 51.0 €.
